Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unenriched emulsified autologous fat transplant for temporomandibular joint osteoarthritis
2024-520244-41-00Phase 2Authorised
- Sponsor
- Tartu University Hospital
- Start
- Mar 2025
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous adipose-derived stromal vascular fraction in Temporomandibular Osteoarthritis, sponsored by Tartu University Hospital. Primary endpoint: Radiological evaluations and questionnaires. Planned start Mar 2025; status: authorised.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
Temporomandibular Osteoarthritis
Beyond the preview
Go deeper on 2024-520244-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520244-41-00.